Table: begin end state 1 20 cytoplasmic 21 42 transmembrane 43 47 non-cytoplasmic 48 69 transmembrane 70 87 cytoplasmic 88 109 transmembrane 110 128 non-cytoplasmic 129 151 transmembrane 152 162 cytoplasmic 163 184 transmembrane 185 203 non-cytoplasmic 204 225 transmembrane 226 245 cytoplasmic 246 267 transmembrane 268 291 non-cytoplasmic 292 317 transmembrane 318 336 cytoplasmic 337 359 transmembrane 360 364 non-cytoplasmic 365 387 transmembrane 388 407 cytoplasmic 408 430 transmembrane 431 436 non-cytoplasmic 437 455 transmembrane 456 470 cytoplasmic
Input: >AO353_24825 FitnessBrowser__pseudo3_N2E3:AO353_24825 MSESIERKGIHLTRALKSRHIFMLSLGGVIGTGLFMGSGVTINQGGPVGAILAYLIAGFL MYLVMVCLGELSVQMPVSGSFQTHATKFIGPATGFMIGWVYWMSWASTVGLEFTAAGMLM VRWFPTVPIWYWSALFVVVLFGLNALATRAFGEAEYWFSGIKVAAILGFIVVGVLVIFGA IPLTSGAPAPMMSNLIGDSLFPNGLPAVFAVMMTVVYAFQGCEIMGVAAGETDQPEKSIP RAVRNVVFRVLIFYVLAIVVLSAIVPWQQAGLMESPFVQVFDMVGIPYAADLMNFVILTA ILSVGNSGLYASTRILWAMSKTGMAPKSLSPLSKRGVPLRALSITLCFALVSLMTSFIAA DTLFMVLMAVSGMSGTVTWIVIALAQYKFRRAYIRDGGKLSDLKYRAPWFPLLPILCIAL CCSLFVFLAMDETQRPSLYWGFGFMALCYGAYFLIQRKRQAVLAPSLPTV
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server